Paltac Corporation
Stock Price Chart
2026/08/16 UpdatedPrice Trend
2026/08/16 UpdatedPrice & Trading Details
2026/08/16 UpdatedPRICE
TRADING
Analyst Recommendations 2 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2019/01/29 | ¥81.80 | ¥87.49 | +7.0% |
| 2016/01/28 | ¥43.59 | ¥49.70 | +14.0% |
| 2015/07/28 | ¥34.64 | ¥45.31 | +30.8% |
| 2015/05/11 | ¥37.55 | ¥38.90 | +3.6% |
Shareholder Composition
Updated 2026/08/01Major Holders
Updated 2026/08/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Third Avenue Trust-THIRD AVENUE VALUE FUND
|
579.6K | -17.40% | |
|
Intl Growth & Income Fd.-Intl Growth and Income Fd.
|
558.9K | 0.00% | |
|
MFS Series Trust V-MFS International New Discovery Fund
|
455.0K | 0.00% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
401.8K | 0.00% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
253.4K | -0.24% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
208.8K | +18.50% |
Dividend History
Updated 2026/08/16| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥63 | -43.8% |
| 2025 | ¥112 | +13.1% |
| 2024 | ¥99 | +15.1% |
| 2023 | ¥86 | +7.5% |
| 2022 | ¥80 | - |
Financial Performance
2026/08/16 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥1,045,734M | ¥1,104,151M | ¥1,151,965M | ¥1,188,097M |
| Gross Profit | ¥81,759M | ¥82,395M | ¥86,358M | ¥88,982M |
| Operating Income | ¥25,921M | ¥24,472M | ¥27,173M | ¥28,009M |
| Pretax Income | ¥28,396M | ¥27,851M | ¥29,401M | ¥32,695M |
| Net Income | ¥19,639M | ¥19,251M | ¥20,638M | ¥22,864M |
| EPS | ¥310.34 | ¥306.33 | ¥328.40 | - |
| Operating Margin | 2.48% | 2.22% | 2.36% | 2.36% |
| Balance Sheet | ||||
| Total Assets | ¥448,877M | ¥476,936M | ¥495,697M | ¥507,048M |
| Total Equity | ¥243,738M | ¥259,695M | ¥277,958M | ¥287,666M |
| Total Liabilities | ¥205,139M | ¥217,241M | ¥217,739M | ¥219,382M |
| Cash | ¥40,670M | ¥45,993M | ¥60,994M | ¥69,916M |
| Interest-bearing Debt | ¥315M | ¥244M | ¥252M | ¥349M |
| Equity Ratio | 54.30% | 54.45% | 56.07% | 56.73% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow | ||||
| Operating CF | ¥21,949M | ¥16,594M | ¥26,790M | ¥20,675M |
| Investing CF | -¥10,170M | -¥6,093M | -¥6,268M | -¥428M |
| Financing CF | -¥8,731M | -¥5,177M | -¥5,520M | -¥11,324M |
| Free CF | ¥12,536M | ¥10,821M | ¥20,986M | ¥19,053M |
| Efficiency | ||||
| ROE | 8.06% | 7.41% | 7.42% | 7.95% |
| ROA | 4.38% | 4.04% | 4.16% | 4.51% |
Latest IR Information
-
Q1 Fiscal Year Ending March 2027 Highlights
Sales of 326.9 billion yen (YoY +3.4%), operating income of 6.1 billion yen (YoY -19.5%), etc., with first-quarter highlights disclosed. Selling, general and administrative expenses are a factor for the increase, and profit remains under pressure on a quarterly basis....
Read more -
Q1 FY2027 Financial Summary (Japan GAAP) for the First Quarter (Non-consolidated)
Net sales 326,927 million yen (YoY +3.4%), operating profit 6,134 million yen (△19.5%), quarterly net income 4,784 million yen (△23.3%), no earnings guidance for FY2027 due to delisting; no dividends planned for the second quarter or fiscal year-end; treasury stock...
Read more -
Notice Regarding the Result of Public Acquisition of Paltech Stock
Disclosure of the result of Medipal Holdings' public acquisition of PALTAC. Purchase price is 6,650 yen per share, acquisition period from 2026-05-12 to 2026-07-07, total acquired shares 28,940,739, expected total voting rights after acquisition 92.64%. TOB success, subsequent squeeze-out procedures...
Read more -
Notice of Record Date for Extraordinary General Meeting of Shareholders | June 19, 2026
PALTAC plans to hold an extraordinary general meeting of shareholders in late August 2026, setting the record date as July 15, 2026. The company will determine the method of share ownership based on the results of the tender offer, with...
Read more -
【PALTAC】2026 Financial Results｜Undetermined Sales (YoY Unsure)
PALTAC Corporation announced its fiscal year 2026 financial results for March. The parent company is Medipal Holdings, which holds a controlling stake. While specific figures for sales and profits are unknown, the document indicates support for a tender offer and...
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥6,650
Rating Score: 2.50 (Based on 2 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Paltac Corporation engages in the wholesale of cosmetics, daily necessities, and over-the-counter drugs in Japan. Paltac Corporation was incorporated in 1928 and is headquartered in Osaka, Japan. Paltac Corporation operates as a subsidiary of MediPal Holdings Corporation.
